JUVÉDERM® is the world's most select collection of dermal fillers* that offers 5 different products to meet your specific needs. Add volume to plump lips, smooth wrinkles or straighten cheeks - we have what you need to get the results you want.
- JUVÉDERM® VOLUMA™ XC injectable gel is intended for deep injection into the cheek area to correct age-related volume loss and chin area augmentation to improve the chin profile in adults over the age of 21.
- JUVÉDERM® VOLLURE™ XC, JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC injectable gels are intended to be injected into facial tissue to correct moderate to severe facial wrinkles and folds, such as nasolabial folds. JUVÉDERM® VOLLURE™ XC injectable gel is intended for adults over the age of 21.
- JUVÉDERM® VOLBELLA™ XC injectable gel is intended to be injected into the lips for lip augmentation and correction of perioral wrinkles in adults over the age of 21.
- JUVÉDERM® Ultra XC injectable gel is intended to be injected into the lips and perioral area for lip augmentation in adults over the age of 21.
Are there any reasons why I should not receive a JUVÉDERM® preparation?
Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or the gram positive bacterial proteins used in these products.
What precautions should my doctor advise me to take?
Limit strenuous exercise and exposure to the sun or heat for 24 hours after treatment. Exposure to any of these factors may cause temporary redness, swelling and/or itching at the injection site.
Tell your doctor if you are pregnant or breastfeeding. The safety of these products during pregnancy or lactation has not been studied.
The safety of JUVÉDERM® VOLUMA™ XC has not been studied in patients under 35 years of age or over 65 years of age for cheek augmentation, or under 22 years of age and over 80 years of age for chin augmentation. The safety of JUVÉDERM® VOLLURE™ XC and JUVÉDERM® VOLBELLA™ XC has not been studied in patients under 22 years of age, and the safety of JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC has not been studied in patients under 18 years of age.
JUVÉDERM® VOLUMA™ XC is intended for use in the chin and cheek areas. JUVÉDERM® VOLLURE™ XC, JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC are intended to be used for facial wrinkles and folds. JUVÉDERM® VOLBELLA™ XC and JUVÉDERM® Ultra XC are intended for use in the lips and perioral area. Safety and effectiveness for treatment of other areas have not been established in clinical studies.
Tell your doctor if you have a history of excessive scarring (thick, hard scars) or pigmentation disorders. The safety of JUVÉDERM® products has not been studied in these patients and may result in additional scarring or pigmentation changes.
Tell your doctor if you are receiving treatment to lower the body's immune response (immunosuppressive therapy). The use of this treatment may lead to an increased risk of infection
Tell your doctor before treatment if you are using substances that can prolong bleeding, such as aspirin, ibuprofen or other blood thinners. As with any injection, this may result in increased bruising or bleeding at the injection site.
Patients with skin lesions near the injection site may be at greater risk of adverse events.
JUVÉDERM® VOLUMA™ XC has not been studied in patients with significant skin laxity on the chin, neck, or jawline.
The effect of JUVÉDERM® VOLUMA™ XC injection in the chin on facial hair growth has not been studied.